These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 27865093)

  • 21. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
    Holme AM; Roland MC; Henriksen T; Michelsen TM
    Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.
    Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Placental oxidative stress and maternal endothelial function in pregnant women with normotensive fetal growth restriction.
    Yoshida A; Watanabe K; Iwasaki A; Kimura C; Matsushita H; Wakatsuki A
    J Matern Fetal Neonatal Med; 2018 Apr; 31(8):1051-1057. PubMed ID: 28367653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of serum and urinary soluble sFlt-1 and PLGF in the diagnosis of preeclampsia.
    Tang P; Xu J; Xie BJ; Wang QM
    Hypertens Pregnancy; 2017 Feb; 36(1):48-52. PubMed ID: 27834501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction.
    Crispi F; Llurba E; Domínguez C; Martín-Gallán P; Cabero L; Gratacós E
    Ultrasound Obstet Gynecol; 2008 Mar; 31(3):303-9. PubMed ID: 18058842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Placental expression of sFlt-1 and PlGF in early preeclampsia vs. early IUGR vs. age-matched healthy pregnancies.
    Hoeller A; Ehrlich L; Golic M; Herse F; Perschel FH; Siwetz M; Henrich W; Dechend R; Huppertz B; Verlohren S
    Hypertens Pregnancy; 2017 May; 36(2):151-160. PubMed ID: 28609172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiogenesis biomarkers for the prediction of severe adverse outcomes in late-preterm preeclampsia.
    Villalain C; Herraiz I; Cantero B; Quezada S; Lopez A; Simón E; Galindo A
    Pregnancy Hypertens; 2020 Jan; 19():74-80. PubMed ID: 31927324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of first-trimester angiogenic factors with placental histological findings in late-onset preeclampsia.
    Triunfo S; Crovetto F; Crispi F; Rodriguez-Sureda V; Dominguez C; Nadal A; Peguero A; Gratacos E; Figueras F
    Placenta; 2016 Jun; 42():44-50. PubMed ID: 27238713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced angiogenic factor expression in intrauterine fetal growth restriction using semiquantitative immunohistochemistry and digital image analysis.
    Alahakoon TI; Zhang W; Arbuckle S; Zhang K; Lee V
    J Obstet Gynaecol Res; 2018 May; 44(5):861-872. PubMed ID: 29392826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maternal Serum Angiogenic Growth Factors in Intrauterine Growth Restriction versus Normal Pregnancies.
    Komwilaisak R; Tangkiratichai P
    J Med Assoc Thai; 2017 Feb; 100(2):119-24. PubMed ID: 29916230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Difference of concentration of placental soluble fms-like tyrosine kinase-1(sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio in severe preeclampsia and normal pregnancy.
    Gurnadi JI; Mose J; Handono B; Satari MH; Anwar AD; Fauziah PN; Yogi Pramatirta A; Rihibiha DD
    BMC Res Notes; 2015 Oct; 8():534. PubMed ID: 26434493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Predictive value of the sFlt1/PlGF ratio for the diagnosis of preeclampsia in high-risk patients].
    Husse S; Gottschlich A; Schrey S; Stepan H; Hoffmann J
    Z Geburtshilfe Neonatol; 2014 Feb; 218(1):34-41. PubMed ID: 24595913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between angiogenic factors and signs of arterial aging in women with pre-eclampsia.
    Akhter T; Wikström AK; Larsson M; Larsson A; Wikström G; Naessen T
    Ultrasound Obstet Gynecol; 2017 Jul; 50(1):93-99. PubMed ID: 27256927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An updated view on the origin and use of angiogenic biomarkers for preeclampsia.
    Huppertz B
    Expert Rev Mol Diagn; 2018 Dec; 18(12):1053-1061. PubMed ID: 30413130
    [No Abstract]   [Full Text] [Related]  

  • 35. Combined screening for early and late pre-eclampsia and intrauterine growth restriction by maternal history, uterine artery Doppler, mean arterial pressure and biochemical markers.
    Litwińska E; Litwińska M; Oszukowski P; Szaflik K; Kaczmarek P
    Adv Clin Exp Med; 2017; 26(3):439-448. PubMed ID: 28791818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population.
    Kienast C; Moya W; Rodriguez O; Jijón A; Geipel A
    J Matern Fetal Neonatal Med; 2016; 29(4):537-43. PubMed ID: 25708492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation.
    Wathén KA; Tuutti E; Stenman UH; Alfthan H; Halmesmäki E; Finne P; Ylikorkala O; Vuorela P
    J Clin Endocrinol Metab; 2006 Jan; 91(1):180-4. PubMed ID: 16263826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of the diagnostic utility of the sFlt-1/PlGF ratio versus PlGF alone for the detection of preeclampsia/HELLP syndrome.
    Stepan H; Hund M; Gencay M; Denk B; Dinkel C; Kaminski WE; Wieloch P; Semus B; Meloth T; Dröge LA; Verlohren S
    Hypertens Pregnancy; 2016 Aug; 35(3):295-305. PubMed ID: 27028698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of preeclampsia with angiogenic biomarkers. Results from the prospective Odense Child Cohort.
    Andersen LB; Dechend R; Jørgensen JS; Luef BM; Nielsen J; Barington T; Christesen HT
    Hypertens Pregnancy; 2016 Aug; 35(3):405-19. PubMed ID: 27159383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Assessment of Soluble FMS-Like Tyrosine Kinase-1/Placental Growth Factor Ratio for the Diagnostic and the Prognosis of Preeclampsia in the Second Trimester.
    Chelli D; Hamdi A; Saoudi S; Jenayah AA; Zagre A; Jguerim H; Bedis C; Sfar E
    Clin Lab; 2016 Oct; 62(10):1927-1932. PubMed ID: 28164532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.